Baltimore-based UPM to acquire Pfizer plant in Tenn.

UPM Pharmaceuticals Inc., a Baltimore-based drug development and contract manufacturer, said it will acquire a 500,000-square-foot commercial manufacturing facility in Bristol, Tenn., that is owned and operated by Pfizer Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *